56 results
6-K
EX-4.4
ENLV
Enlivex Therapeutics Ltd
29 May 24
Enlivex Therapeutics Closes up to $15 Million Registered Direct Offering
4:20pm
market transaction or otherwise) or the Holder’s brokerage firm otherwise purchases for the Holder, Ordinary Shares to deliver in satisfaction
6-K
EX-4.5
ENLV
Enlivex Therapeutics Ltd
29 May 24
Enlivex Therapeutics Closes up to $15 Million Registered Direct Offering
4:20pm
market transaction or otherwise) or the Holder’s brokerage firm otherwise purchases for the Holder, Ordinary Shares to deliver in satisfaction of a sale
6-K
EX-4.2
ENLV
Enlivex Therapeutics Ltd
29 May 24
Enlivex Therapeutics Closes up to $15 Million Registered Direct Offering
4:20pm
, Ordinary Shares to deliver in satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving upon such exercise (a “Buy
6-K
EX-4.1
ENLV
Enlivex Therapeutics Ltd
29 May 24
Enlivex Therapeutics Closes up to $15 Million Registered Direct Offering
4:20pm
Shares to deliver in satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving upon such exercise (a “Buy
6-K
EX-1.1
ENLV
Enlivex Therapeutics Ltd
29 May 24
Enlivex Therapeutics Closes up to $15 Million Registered Direct Offering
4:20pm
at the Closing. Upon satisfaction of the covenants and conditions set forth in Sections 2.2 and 2.3, the Closing shall occur at the offices of Company U.S … ) other general corporate purposes. The Company shall not use such proceeds: (a) for the satisfaction of any portion of the Company’s debt (other than
6-K
EX-4.3
osvwxuy
29 May 24
Enlivex Therapeutics Closes up to $15 Million Registered Direct Offering
4:20pm
6-K
EX-5.1
3xcg1im
29 May 24
Enlivex Therapeutics Closes up to $15 Million Registered Direct Offering
4:20pm
6-K
EX-5.2
nhgrmso on501
29 May 24
Enlivex Therapeutics Closes up to $15 Million Registered Direct Offering
4:20pm
424B5
8jmwuf
29 May 24
Prospectus supplement for primary offering
4:15pm
6-K
EX-99.1
hq24z78fg72urvm8 ma
28 May 24
Enlivex Therapeutics Announces up to $15 Million Registered Direct Offering
8:13am
6-K
fc8tktz 9bug9nw
28 May 24
Enlivex Therapeutics Announces up to $15 Million Registered Direct Offering
8:13am
6-K
EX-5.1
n1xfmxv4q00wuk0
30 Dec 22
Report of Foreign Private Issuer
4:02pm
6-K
EX-10.1
aukce35fqmt zjw
30 Dec 22
Report of Foreign Private Issuer
4:02pm
F-3
EX-5.2
yvhe6
29 Apr 22
Shelf registration (foreign)
8:14am
F-3
EX-5.1
nfn04dvps97cv59
29 Apr 22
Shelf registration (foreign)
8:14am